Outcomes After Cardioversion in Atrial Fibrillation Patients Treated with Non-Vitamin K Antagonist Oral Anticoagulants (NOACs): Insights from a Meta-Analysis

Conclusions Data from patients enrolled in RCTs, showed that NOACs are effective and safe for AF patients undergoing cardioversion.
Source: American Journal of Cardiovascular Drugs - Category: Cardiology Source Type: research